Hamilton County is suing pharmacy benefit managers and drug manufacturers over the price of insulin. County Prosecutor Connie Pillich says pharmacy benefit managers (or PBMs) and manufacturers ...
Adults with type 2 diabetes who used an automated insulin delivery system had greater improvements in HbA1c than controls ...
MannKind Corporation (Nasdaq: MNKD) , a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions for cardiometabolic and orphan lung ...
A groundbreaking new study offers hope that people with diabetes may no longer need to take insulin injections every day. The research, published in Science Translational Medicine, was led by ...
Developed under the direction of Assistant Professor Shady Farah of the Technion's Faculty of Chemical Engineering, and carried out with colleagues from MIT, Harvard University, Johns ...
A pioneering study marks a major step toward eliminating the need for daily insulin injections for people with diabetes. The ...
The Trump administration announced that the company, a pharmacy benefit manager, had agreed to make significant changes to ...
The FDA has approved a label update for an inhaled insulin indicated for adults with type 1 or type 2 diabetes, according to ...
New Afrezza prescribing information outlines higher starting dose conversions for patients transitioning from mealtime ...
12don MSN
Beyond the brand names: Everything you need to know about Ozempic and other GPL-1 medications
Ozempic has become so embedded in global culture that “Ozempic face” was shortlisted for a prominent dictionary’s word of the ...
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a biopharmaceutical company dedicated to transforming chronic disease care through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results